Subscribe to our Newsletters !!
In the Pharmaceutical industry, maintaining asepti
Labs today face mounting pressure to cut carbon em
Dr. Mohammed Enayat’s recent testimony on his ag
It is with utmost pride that Microbioz India annou
30th June, 2025 Mumbai: Alembic Pharmaceuticals Li
Since it’s an ingredient in so many foods, you h
In our cover story, we shine a spotlight on “ The Magazine
The U.S. Food and Drug Administration has endorsed a medication to treat newborn children and kids with HIV, with the medication having been created by drugmaker GlaxoSmithKline’s HIV drugs division ViiV Healthcare, the FDA and the GSK unit said.
The FDA said on Friday it was conceding Viiv the endorsement of Tivicay and Tivicay PD tablets “for suspension to treat HIV-1 disease in pediatric patients at any rate a month old and weighing in any event 3 kgs in blend with other antiretroviral medicines”.
The medication is at present under audit by the European Medicines Agency, ViiV, in which Pfizer and Shionogi have little stakes, said in a different articulation.
